HRA005191
Title:
Immune Correlates of Response and Resistance to Neoadjuvant Chemo-immunotherapy in Non-small Cell Lung Cancer
Release date:
2025-03-29
Description:
To understand mechanisms of primary resistance, we followed a sufficiently large cohort of NSCLC patients receiving neoadjuvant immunotherapy, and profiled post-treatment samples using single-cell RNA and T cell receptor (TCR) sequencing. By associating tumor immune microenvironment (TIME) with response, we uncovered heterogeneous mechanisms of response and major mechanisms of primary resistance, providing insights into strategic developments of combination regimens.
Data Accessibility:   
Controlled access Request Data
BioProject:
Study type:
Disease Study
Disease name:
non-small cell lung carcinoma
Data Access Committee

For each controlled access study, there is a corresponding Data Access Committee(DAC) to determine the access permissions. Access to actual data files is not managed by NGDC.


DAC NO.:
DAC name:
DAC_ZhangLab
Contact person:
Cheng Sijin
Email:
chengsj@mail.cbi.pku.edu.cn
Description:
BIOPIC, Beijing Advanced Innovation Center for Genomics, and School of Life Sciences
Individuals & samples
Submitter:   Zhang Zemin / zemin@pku.edu.cn
Organization:   Peking University
Submission date:   2023-07-09
Requests:   14